School of Medicine

Wayne State University School of Medicine

Profile View

Evanthia Bernitsas
Title
Assistant Professor of Neurology, Associate Director of the Multiple Sclerosis Center
Phone
(313) 745-4275
Profile

Evanthia Triantafylou-Bernitsas, MD joined the Department of Neurology at Wayne State University in 2011. She is a board certified Neurologist and a Multiple Sclerosis specialist. Currently, she serves as Assistant Professor of Neurology and Associate Director of the Multiple Sclerosis Center at Wayne State School of Medicine.

Her clinical and research interests include tremor in MS, epilepsy and MS, clinical management of MS and MS variants. She is the PI and co-PI in multiple MS -related clinical trials. She is actively involved in medical students� and neurology residents� education.

 

 

Medical

Aristotelian Medical School, Thessaloniki, Greece, MD, 1990

Internship

Partners, St. Vincent Hospital, Toledo, OH, 2004-2005

Residency
  • AHEPA/Theagenion Hospital, Thessaloniki, Greece, 1990-1993
  • Mercy Health Partners, Toledo, OH, 2004-2005
  • Case Western Reserve University, University Hospitals of Cleveland, Cleveland, OH, 2005-2008
Fellowships
  • Walter Reed Army Medical Center, NIH/USUHS, Research Fellow, Bethesda, MR, 1993-1995
  • University of Michigan, Neuroscience Research, Ann Arbor, MI, 2000-2001
  • University of Michigan, Neurorology Research, Ann Arbor, MI, 2001-2004 Maxine Mesinger Comprehensive MS Center, Baylor College of Medicine, Multiple Sclerosis, Houston, TX, 2008-2009
Prior Appointments

University of Michigan, Assistant Professor, 2009-2011

Interests
  • MS and epilepsy
  • Intractable tremor in MS and deep brain stimulation (DBS)
  • RLS: pathophysiology and treatment, movement disorders
Publications

Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, and the CAMMS 223 Study Investigators (Bernitsas E, Member and Co-I). Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial. Neurology 2012;78:1069-1078

 Lindsey J, Scott T, Lynch S, Cofield S, Nelson F, Conwit R, and the CombiRx Investigators Group (Bernitsas, E Member and Co-I). The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics. Mult Scler Relat Disord. 2012;1: 81-86

 Bernitsas E. Clinical Neuroimmunology: MS and related disorders. Book review. Journal of Neurological Sciences, V320, issue 1, p169, 15 September 2012

Bernitsas E, Wei W, Mikol, DD: Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane. Annals of Neurology. 59 (1), 206-209, 2006.

Awards & Honors

2012-2013 Best Doctors in America and in Michigan

 MS Clinical Fellowship Award, National MS Society, 2008-2009